758

83 66. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome / J.W. Huggins, C.M. Hsiang, T.M. Cosgriff [et al.] // J Infect Dis. – 1991. – Vol. 164, №6. – P. 1119-1127. doi: 10.1093/infdis/164.6.1119. 67. Risk of Venous Thromboembolism Following Hemorrhagic Fever With Renal Syndrome:ASelf-controlled Case Series Study /A-M. Connolly- Andersen, H. Whitaker [et al.] // Clinical Infectious Diseases. ‒ 2018. ‒ Vol. 66, №2. ‒ P. 268–273. doi: 10.1093/cid/cix777. 68. SurvivingSepsisCampaign: International Guidelines forManagement of Sepsis and Septic Shock 2021. Critical Care Medicine 49(11):p e1063-e1143, November 2021. | DOI: 10.1097/CCM.0000000000005337. 69. The pathogenesis of nephropathia epidemica: new knowledge and unanswered questions / J. Mustonen, S. Mäkelä, T. Outinen, O. Laine [et al.] // Antiviral research. – 2013. – Vol. 100, №3. – P. 589–604. doi: 10.1016/j. antiviral.2013.10.001. 70. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) / M. Singer, C.S. Deutschman, C.W. Seymour [et al.] // JAMA. – 2016. – Vol. 315, №8. – P. 801–810. doi: 10.1001/jama.2016.0287. 71. The assessment of hantaan virus-specific antibody responses after the immunization program for hemorrhagic fever with renal syndrome in NorthwestChina/Z.Li,H.Zeng,Y.Wang[et al.] //Hum.Vaccin.Immunother.– 2017. – Vol. 13, №4. – P. 802–807. doi: 10.1080/21645515.2016.1253645. 72. Three asymptomatic animal infection models of hemorrhagic fever with renal syndrome caused by hantaviruses / C.C. Perley, R.L. Brocato, S.A. Kwilas [et al.] // PLoS ONE. – 2019. – Vol. 14, №5. ‒ e0216700. doi: 10.1371/journal pone.0216700. 73. Yang, L.Acute Kidney Injury inAsia / L. Yang // Kidney Dis (Basel). – 2016. – Vol. 2, №3. – P. 95–102. doi: 10.1159/000441887. 74. Young patient with hantavirus-induced myocarditis detected by comprehensive cardiac magnetic resonance assessment / P. Krumm, T. Zitzelsberger, M. Gawaz, S. Greulich // BMC Infect Dis. – 2019. ‒ Vol. 19, №1. ‒ P. 15. doi: 10.1186/s12879-018-3658-8.